D. Serraino et al., AIDS-ASSOCIATED KAPOSIS-SARCOMA AND NON-HODGKINS-LYMPHOMAS REPORTING IN ITALY - A LINKAGE STUDY, Journal of acquired immune deficiency syndromes, 7(11), 1994, pp. 1202-1207
To evaluate the completeness and accuracy in the reporting of AIDS-ass
ociated Kaposi's sarcoma (KS) and non-Hodgkin's lymphomas (NHL) in Ita
ly, a linkage study of the notifications to the Italian AIDS Registry
(RAIDS-the national compulsory AIDS surveillance system) and the clini
cal and pathological records of the Italian Cooperative Group on AIDS-
related tumors (GICAT-a nationwide voluntary reporting system for HIV-
infected individuals who develop cancer) was carried out. A total of 2
88 cases of KS and 258 cases of NHL fulfilling the AIDS definition cri
teria, histologically diagnosed by the GICAT centers between January 1
987 and March 1992, were matched with the 16,860 AIDS cases reported t
o the RAIDS up to March 1993. The linkage procedure, based on name, ge
nder, and date of birth, identified 276 cases of KS (96%) and 241 case
s of NHL (93%) present in both files (''linked'' cases). The diagnosis
of KS did not appear among the clinical manifestations of AIDS in the
RAIDS file in 67 out of the 276 linked KS (24%), either with coincide
nt dates of KS diagnosis and of case notification (19 cases) or when t
he KS diagnosis followed by greater than or equal to 2 months the case
notification to RAIDS (48 cases). Of the 241 linked NHL, 84 (33%) had
no such neoplastic complications of AIDS listed in the RAIDS tile, 23
with coincident dates of NHL diagnosis and of case notification and 6
1 with the NHL diagnosis made greater than or equal to 2 months after
the notification. A noteworthy discrepancy in the classification of th
e three histologic subtypes of NHL emerged between the GICAT and the R
AIDS, The degree of underreporting of AIDS-associated cancers that eme
rged from the present study suggests that augmentation with other sour
ces of oncological information is important to better estimate the bur
den of AIDS-related tumors and to study the interaction between HIV in
fection and cancer.